期刊文献+

糖尿病肾病患者心脏结构与功能研究进展

Research progress of cardiac structure and function in patients with diabetic nephropathy
原文传递
导出
摘要 糖尿病肾病(DN)是糖尿病微血管最常见的并发症之一。DN患者往往伴发心血管疾病。DN患者随着蛋白尿升高、肾小球滤过率下降及血肌酐水平的升高常伴发心脏功能、结构的改变,导致心血管疾病的发生。另外炎症因子对心脏结构与功能影响也具有重要作用,深入了解炎症在DN心血管疾病的病理生理作用,明确DN患者心脏结构与功能关系,对其预防和治疗具有重要意义。 Diabetic nephropathy(DN)is a common microvascular complication of diabetes mellitus.Cardiovascular disease often occurs in patients with DN.Patients with DN often experience changes in cardiac structure and function as proteinuria increases,glomerular filtration rate decreases,and blood creatinine levels increase,leading to the occurrence of cardiovascular disease.Additionally,inflammatory factors play a crucial role in cardiac structure and function.Understanding the pathological and physiological effects of inflammation on diabetic nephropathy-related cardiovascular disease and clarifying the relationship between cardiac structure and function in patients with DN are crucial for effective prevention and treatment of DN.
作者 纪慕秋 郑仁东 Ji Muqiu;Zheng Rendong(Department of Endocrinology,Hospital of Integrated Traditional and Western Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing 210046,Jiangsu Province,China)
出处 《中国基层医药》 CAS 2024年第2期317-320,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 糖尿病肾病 心脏 蛋白尿 肾小球滤过率 炎症趋化因子类 综述 Diabetic nephropathies Heart Proteinuria Glomerular filtration rate Chemokines Review
  • 相关文献

参考文献9

二级参考文献76

  • 1张曹进,冯颖青,陈富荣,吴玥婷,林秋伟.并或不并高血压的代谢综合征患者左室结构和功能特点[J].中华高血压杂志,2006,14(8):643-646. 被引量:2
  • 2Ma YC ,Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Am Soc Nephro1,2006,17:2937-2944.
  • 3Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, Hypertension, and Diabetes. Circulation ,2004,110:32-35.
  • 4Fuarles LD, Sherrard DJ, Adler S, et al. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. Am Soc Nephrol,2005,14:577-580.
  • 5侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 6Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens, 2011320(6) :631-639.
  • 7Qutb A, Syed G, Tamim HM, et al. Cystatin C-based formula is superior to MDRD, Cockcroft-Gault and Nankivell formulae in estimating the glomerular filtration rate in renal allografts. Exp Clin Transplant, 2009 , 7 (4):197-202.
  • 8Hois R, Beve S, Ekart R, et al. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. Clin Nephrol, 2008 , 70(1): 10-17.
  • 9Cheng XW, Huang Z, Kuzuya M, et al. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension,2011 ,58(6) :978-986.
  • 10Turner R, Cull C, Holman R. 4K prospeeteetive diabetes study 17: A nine-year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med, 1996;124(1 Pt 2):134.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部